| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.006 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |